Kiniksa Pharmaceuticals International plc.

KNSA

NASDAQHealth Care

Income Statement

Total Revenue$423.24M

Gross Profit$362.33M

Operating Income$-45.62M

EBITDA$-31.32M

EBIT$-36.15M

Pre-tax Income$88.87M

Net Income$-43.19M

Cash Equivalent$130.33M

Total Debt$11M

Book Value$435.61M

Book Value Per Share6.11

Return on Equity (ROE)-9.85%

Return on Assets (ROA)-7.44%

Return on Invested Capital (ROI)-9.85%

Net Profit Margin-10.21%

Current Ratio3.30

Quick Ratio2.84

Long-Term Debt / Equitynull